Keywords: درمان بیماری اصلاح; Demyelination; Multiple sclerosis; Pediatric; Incidental findings; ADEM; acute disseminated encephalomyelitis; CIS; clinically isolated syndrome; CNS; central nervous system; DIS; dissemination in space; DIT; dissemination in time; DMT; disease modifying
مقالات ISI درمان بیماری اصلاح (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: درمان بیماری اصلاح; Multiple sclerosis; Disease modifying therapy; Microglia; Positron emission tomography; TSPO; [11C]DPA713;
Keywords: درمان بیماری اصلاح; DBSI; diffusion basis spectrum imaging; DTI; diffusion tensor imaging; DMT; disease modifying therapy; ADC; apparent diffusion coefficient; PBH; persistent black hole; WM; white matter; GM; gray matter; Multiple sclerosis; Diffusion tensor imaging; Inflam
Keywords: درمان بیماری اصلاح; DMT; disease modifying therapy; EDSS; expanded disability status scale; IFN; interferon; Multiple sclerosis; Disease modifying; Adherence;
Keywords: درمان بیماری اصلاح; MS; Multiple Sclerosis; PRIMS; Pregnancy In Multiple Sclerosis; EDSS; Expanded Disability Status Scale; DMT; disease modifying therapy; IVIg; intravenous immunoglobulin; GA; glatiramer acetate; INF; interferon; IM; intramuscular; EA; epidural analgesia; C
Keywords: درمان بیماری اصلاح; DMT; disease modifying therapy; EDSS; Expanded Disability Status Scale; MRI; magnetic resonance imaging; MS; multiple sclerosis; Relapsing-remitting multiple sclerosis; Disease modifying therapy; Natalizumab; Fingolimod; Alemtuzumab; Systematic review;
Keywords: درمان بیماری اصلاح; Multiple sclerosis; Cognitive impairment; Dementia; Unemployment; Disease modifying therapy; MRI; Monitoring; Treating to target; Disease activity free;
Keywords: درمان بیماری اصلاح; MS; multiple sclerosis; DMT; disease modifying therapy; RRMS; relapsing-remitting MS; NEDA; no evidence of disease activity; N/E; new or enlarging; GdE; gadolinium enhancing; KP; knowledge program; EQ-5D; European Quality of Life 5-Dimensions; PS; Perform
Keywords: درمان بیماری اصلاح; Multiple sclerosis; Disease modifying therapy; Clinical trial risk; Biologics; Small molecules; New drug development;
Keywords: درمان بیماری اصلاح; Type 1 diabetes; Clinical trials; Disease modifying therapy; Diabetes TrialNet
Keywords: درمان بیماری اصلاح; Multiple sclerosis; Autoimmune disease; Disease modifying therapy; Thyroid disease; Interferon-Beta;
Keywords: درمان بیماری اصلاح; Multiple sclerosis; Demyelination; Optic neuritis; Myelitis; Disease modifying therapy;
Keywords: درمان بیماری اصلاح; Multiple sclerosis; Disease modifying therapy; Relapse; Patient survey; Patient perspective;
Keywords: درمان بیماری اصلاح; QOL; Quality of life; DMT; Disease modifying therapy; UCSF; University of California, San Francisco; Ped QOL; Pediatric Quality of Life Inventory; TRAQ; Transition readiness assessment questionnaire; HCAQ; Healthcare skills assessment questionnaire; SES;
Keywords: درمان بیماری اصلاح; disease modifying therapy; multiple sclerosis;
Keywords: درمان بیماری اصلاح; Multiple sclerosis; Disease modifying therapy; Relapse activity; Disability progression; Symptom worsening; Patient-reported outcomes; PDDS
The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis
Keywords: درمان بیماری اصلاح; Tysabri; Gilenya; Drug sequencing; Disease modifying therapy; Washout period;
Predictors of relapse and disability progression in MS patients who discontinue disease-modifying therapy
Keywords: درمان بیماری اصلاح; Multiple sclerosis; Relapse; Disability; Disease modifying therapy; Observational cohort study;
NEDA treatment target? No evident disease activity as an actionable outcome in practice
Keywords: درمان بیماری اصلاح; No evident disease activity; Multiple sclerosis; Disease modifying therapy; Outcome measures; Treatment target;
Review articleClassifying PML risk with disease modifying therapies
Keywords: درمان بیماری اصلاح; Disease modifying therapy; Multiple sclerosis; Progressive multifocal leukoencephalopathy; Natalizumab; Fingolimod; Dimethyl fumarate; Rituximab;
B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro
Keywords: درمان بیماری اصلاح; CNS; central nervous system; DMEM; Dulbecco's modified essential medium; DMT; disease modifying therapy; EBV; Epstein-Barr virus; FGF; fibroblast growth factor; GM-CSF; granulocyte macrophage-colony stimulating factor; IFN; interferon; Ig; immunoglobulin;
How global MS prevalence is changing: A retrospective chart review in the United Arab Emirates
Keywords: درمان بیماری اصلاح; Multiple sclerosis; United Arab Emirates (UAE); Prevalence; Incidence; Disease modifying therapy; Epidemiology;
Effect of switching from intramuscular interferon β-1a to oral fingolimod on time to relapse in patients with relapsing-remitting multiple sclerosis enrolled in a 1-year extension of TRANSFORMS
Keywords: درمان بیماری اصلاح; DMT; disease modifying therapy; EDSS; Expanded Disability Status Scale; IFNβ-1a; interferon beta-1a; IM; intramuscular; MS; multiple sclerosis; TRANSFORMS; Trial Assessing Injectable Interferon Versus Fingolimod Oral in Relapsing-Remitting Multiple Scl
Risk tolerance to MS therapies: Survey results from the NARCOMS registry
Keywords: درمان بیماری اصلاح; MS; multiple sclerosis; NARCOMS; North American Research Committee on Multiple Sclerosis; RT; Risk Tolerance; DMT; disease modifying therapy; PML; progressive multifocal leukoencephalopathy; IRB; Institutional Review Board; SG; standard gamble; CureMS; cu
Is it time to target no evident disease activity (NEDA) in multiple sclerosis?
Keywords: درمان بیماری اصلاح; No evident disease activity; NEDA; Multiple sclerosis; Disease modifying therapy; Treating to target; Disease activity free;
Abnormal blood–brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI
Keywords: درمان بیماری اصلاح; MRI; DCE MRI; Perfusion MRI; Blood–brain barrier; Disease modifying therapy; Multiple sclerosis
Accounting for disease modifying therapy in models of clinical progression in multiple sclerosis
Keywords: درمان بیماری اصلاح; Disease modifying therapy; Disease progression; Longitudinal analysis; Multiple sclerosis; Statistical modeling;
The future of Alzheimer's disease: The next 10 years
Keywords: درمان بیماری اصلاح; Alzheimer's disease; Prodromal; Asymptomatic; Preclinical; Mild cognitive impairment; Review; Dementia; Neurodegeneration; Network paradigm; Systems biology; Systems neurophysiology; Amyloid β; Biomarkers; Imaging; CSF; Disease modifying therapy; Preventi
Multiple Sclerosis
Keywords: درمان بیماری اصلاح; Multiple sclerosis; Disease modifying therapy; Magnetic resonance imaging; Optic neuritis